FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793372931> ?p ?o ?g. }

• W2793372931 abstract "No new therapies for traumatic brain injury (TBI) have been officially translated into current practice. At the tissue and cellular level, both inflammatory and oxidative processes may be exacerbated post-injury and contribute to further brain damage. N-acetylcysteine (NAC) has the potential to downregulate both processes. This review focuses on the potential neuroprotective utility of NAC and N-acetylcysteine amide (NACA) post-TBI.Medline, Embase, Cochrane Library, and ClinicalTrials.gov were searched up to July 2017. Studies that examined clinical and laboratory effects of NAC and NACA post-TBI in human and animal studies were included. Risk of bias was assessed in human and animal studies according to the design of each study (randomized or not). The primary outcome assessed was the effect of NAC/NACA treatment on functional outcome, while secondary outcomes included the impact on biomarkers of inflammation and oxidation. Due to the clinical and methodological heterogeneity observed across studies, no meta-analyses were conducted.Our analyses revealed only three human trials, including two randomized controlled trials (RCTs) and 20 animal studies conducted using standardized animal models of brain injury. The two RCTs reported improvement in the functional outcome post-NAC/NACA administration. Overall, the evidence from animal studies is more robust and demonstrated substantial improvement of cognition and psychomotor performance following NAC/NACA use. Animal studies also reported significantly more cortical sparing, reduced apoptosis, and lower levels of biomarkers of inflammation and oxidative stress. No safety concerns were reported in any of the studies included in this analysis.Evidence from the animal literature demonstrates a robust association for the prophylactic application of NAC and NACA post-TBI with improved neurofunctional outcomes and downregulation of inflammatory and oxidative stress markers at the tissue level. While a growing body of scientific literature suggests putative beneficial effects of NAC/NACA treatment for TBI, the lack of well-designed and controlled clinical investigations, evaluating therapeutic outcomes, prognostic biomarkers, and safety profiles, limits definitive interpretation and recommendations for its application in humans at this time." @default.
• W2793372931 created "2018-03-29" @default.
• W2793372931 creator A5015063439 @default.
• W2793372931 creator A5023300205 @default.
• W2793372931 creator A5033111250 @default.
• W2793372931 creator A5033177613 @default.
• W2793372931 creator A5036363551 @default.
• W2793372931 creator A5055901163 @default.
• W2793372931 creator A5066184385 @default.
• W2793372931 date "2018-01-15" @default.
• W2793372931 modified "2023-10-16" @default.
• W2793372931 title "Systematic Review of Human and Animal Studies Examining the Efficacy and Safety of N-Acetylcysteine (NAC) and N-Acetylcysteine Amide (NACA) in Traumatic Brain Injury: Impact on Neurofunctional Outcome and Biomarkers of Oxidative Stress and Inflammation" @default.
• W2793372931 cites W1582835139 @default.
• W2793372931 cites W1589710900 @default.
• W2793372931 cites W1657276338 @default.
• W2793372931 cites W1887374608 @default.
• W2793372931 cites W1970796115 @default.
• W2793372931 cites W1973309192 @default.
• W2793372931 cites W1974151084 @default.
• W2793372931 cites W1974876299 @default.
• W2793372931 cites W1983759041 @default.
• W2793372931 cites W1984583584 @default.
• W2793372931 cites W1987396857 @default.
• W2793372931 cites W1988808659 @default.
• W2793372931 cites W1996450257 @default.
• W2793372931 cites W1998145026 @default.
• W2793372931 cites W2000232520 @default.
• W2793372931 cites W2001068966 @default.
• W2793372931 cites W2009178440 @default.
• W2793372931 cites W2021217784 @default.
• W2793372931 cites W2028792230 @default.
• W2793372931 cites W2030520823 @default.
• W2793372931 cites W2034679108 @default.
• W2793372931 cites W2046305641 @default.
• W2793372931 cites W2047554110 @default.
• W2793372931 cites W2049173294 @default.
• W2793372931 cites W2063209437 @default.
• W2793372931 cites W2065068592 @default.
• W2793372931 cites W2066442550 @default.
• W2793372931 cites W2066881685 @default.
• W2793372931 cites W2069687106 @default.
• W2793372931 cites W2071425128 @default.
• W2793372931 cites W2072380594 @default.
• W2793372931 cites W2074086852 @default.
• W2793372931 cites W2074447472 @default.
• W2793372931 cites W2075455140 @default.
• W2793372931 cites W2080052117 @default.
• W2793372931 cites W2084646646 @default.
• W2793372931 cites W2085161690 @default.
• W2793372931 cites W2086391866 @default.
• W2793372931 cites W2090411921 @default.
• W2793372931 cites W2095764747 @default.
• W2793372931 cites W2099204286 @default.
• W2793372931 cites W2100638277 @default.
• W2793372931 cites W2100769394 @default.
• W2793372931 cites W2105388269 @default.
• W2793372931 cites W2106757656 @default.
• W2793372931 cites W2110348412 @default.
• W2793372931 cites W2119624946 @default.
• W2793372931 cites W2119701105 @default.
• W2793372931 cites W2123532637 @default.
• W2793372931 cites W2124107177 @default.
• W2793372931 cites W2129449220 @default.
• W2793372931 cites W2132754272 @default.
• W2793372931 cites W2137368645 @default.
• W2793372931 cites W2139543340 @default.
• W2793372931 cites W2141923055 @default.
• W2793372931 cites W2144376710 @default.
• W2793372931 cites W2149736600 @default.
• W2793372931 cites W2162660365 @default.
• W2793372931 cites W2164200221 @default.
• W2793372931 cites W2164461155 @default.
• W2793372931 cites W2170602294 @default.
• W2793372931 cites W2170807824 @default.
• W2793372931 cites W2274542647 @default.
• W2793372931 cites W2289081559 @default.
• W2793372931 cites W2331141065 @default.
• W2793372931 cites W2399819377 @default.
• W2793372931 cites W240506283 @default.
• W2793372931 cites W2416151618 @default.
• W2793372931 cites W2508362814 @default.
• W2793372931 cites W2566428467 @default.
• W2793372931 cites W2571978827 @default.
• W2793372931 cites W2591558715 @default.
• W2793372931 cites W2616329892 @default.
• W2793372931 cites W2622258949 @default.
• W2793372931 cites W2731637927 @default.
• W2793372931 cites W2736091234 @default.
• W2793372931 cites W3022903699 @default.
• W2793372931 cites W566748824 @default.
• W2793372931 doi "https://doi.org/10.3389/fneur.2017.00744" @default.
• W2793372931 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5776005" @default.
• W2793372931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29387038" @default.
• W2793372931 hasPublicationYear "2018" @default.
• W2793372931 type Work @default.
• W2793372931 sameAs 2793372931 @default.
• W2793372931 citedByCount "53" @default.
• W2793372931 countsByYear W27933729312018 @default.
• W2793372931 countsByYear W27933729312019 @default.
• W2793372931 countsByYear W27933729312020 @default.

• next